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Objective: to evaluate the condition of organ donor arteries subjected to prolonged cold-ischaemia followed by cryopre-
servation, for their possible use as vascular grafts.
Materials and methods: fresh specimens of human iliac artery from organ donors were used as controls. These arteries
were divided into two portions, one of which was cryopreserved in an automated freezer. A further group of arteries was
immersed in Wisconsin solution and kept for 4 days at 4 C (cold-ischaemia). After this period, the arteries were also cut
into two, and one of these portions was cryopreserved. All the cryopreserved arterial segments were stored for a month and
then subjected to automated gradual thawing. The thawed specimens were evaluated by light microscopy, scanning and
transmission electron microscopy, immunohistochemical analysis (MMPs, elastin, CD31, von Willebrand factor) and the
in situ detection of fragmented DNA (TUNEL method).
Results: the most marked changes induced by cryopreservation were partial vessel deendothelialisation and morphological
changes in cells of the intima that were in the process of detachment. No significant changes were observed in the medial
layer, other than discrete elastic fibre fragmentation. Following cold-ischaemia, the endothelium was the most affected layer,
with large denuded areas and exposure of the fibroelastic layer. Increased MMP-2 expression was also noted after cold-
ischaemia. When subjected to both cold-ischaemia and cryopreservation, a large proportion of endothelial cells showed
positivity for the TUNEL technique, however, no significant difference was observed between the ischaemic and the
ischaemic/cryopreserved specimens.
Conclusions: prolonged cold-ischaemia causes some additional damage to the arterial wall compared to cryopreservation
alone. However, the structural component of the ischaemic vessel remains in a condition that is suitable for subsequent
cryopreservation and use as a vessel substitute or a scaffold for tissue engineering.
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In vascular reconstruction autologous vessels are most
frequently used. In lack of suitable autologous vessels
a possible, alternative is an allograft from a multi-
organ donor.
The cryostorage of such vessels in liquid nitrogen
accompanied by cryoprotectant substances has
proved to be the most effective method of preserving
the morphological properties of these vessels.1±4
Adequate preservation of a functional vascular endo-
thelium is essential in maintaining vessel tone and
antithrombogenic properties.5Please address all correspondence to: J. BujaÂn, Department of
Morphological Sciences and Surgery, Faculty of Medicine, Univer-
sity of AlcalaÂ, Ctra. Madrid-Barcelona Km 33.6, 28871-Madrid,
Spain.
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sel banks has not led to a proportional increase in the
supply of graft specimens and there is still a need to
make use of any vessel that may become available.
Currently, a proportion of the vessels used as allo-
grafts is provided by those destined for use reserve
vessels during organ transplant.
Hence, the present study was designed to establish
whether vessels kept at 4 C during the post-trans-
plant `` stand-by'' period might still be of use as vas-
cular allografts following cryopreservation.
Materials and Methods
Vessel procurement
The iliac arteries employed in this study were har-
vested under a programme established to retrievel rights reserved.
24 G. Pascual et al.multiorgan transplant tissue. Donor age was 20±60
years. The study protocol was approved by the local
ethics committee.
Once flushed with Wisconsin solution to remove
any residual intra-arterial blood, each vessel was
divided in two. Procured arteries to be used as
fresh controls were directly processed for the dif-
ferent analytical techniques (Fresh group). The
second fresh artery segment was directly cryopre-
served (Fresh. Cryo group). A second set of specimens
were flushed, immersed in Wisconsin solution and
subjected to a period of cold-ischaemia for 4 days at
4 C (Isch. group). After the period of cold-ischaemia,
half of each artery was cryopreserved (Isch. Cryo
group).
Cryopreservation
Fresh and cold-ischaemic arterial segments were
immersed in the cryopreservation solution composed
of Wisconsin solution plus dimethylsulphoxide
(DMSO) as the cryoprotectant, at a proportion of
9 : 1. To reduce osmotic effects, the DMSO was added
gradually in 4 successive 5 min steps, increasing the
DMSO concentration each time until 10% (2.5%, 5%,
7.5% and 10%). The specimens were then subjected to
automated, controlled cryopreservation in a bio-
logical freezer (CM25 P.115 Carburos MetaÂlicos S.A.,
Madrid, Spain) at a cooling rate of 1C/min until
approximately ÿ120 C. Finally, the frozen arterial
specimens were immersed in liquid nitrogen at
ÿ196 C and stored for 30 days.
Thawing
After the storage period, frozen specimens were sub-
jected to a gradual thawing process in the same bio-
logical freezer.1,2 The warming rate was 1C/min until
room temperature. Once thawed, the DMSO was
removed by rinsing in tapered serial dilutions of the
cryoprotectant.
Experimental design
The following groups were established:
 Fresh group (n 10): fresh arterial were divided in
two segments to be used as controls (Fresh; n 10)
and as fresh arterial segments subjected to cryopre-
servation (Fresh. Cryo; n 10).Eur J Vasc Endovasc Surg Vol 24, July 2002 Cold-ischaemia group (n 10): were used as
arterial segments subjected to a 4-day period of
cold-ischaemia at 4 C (Isch; n 10); and arterial
segments cryopreserved after the period of cold-
ischaemia (Isch. Cryo; n 10).
Morphological analysis
All the arterial specimens were processed for light
microscopy and scanning and transmission electron
microscopy.
Specimens for light microscopy were fixed by
immersion in 10% formaldehyde and embedded in
paraffin to obtain sections 5 mm-thick. These speci-
mens were then deparaffinated and hydrated, and
finally stained with haematoxylin-eosin, Masson's tri-
chrome stain and orcein.
For the ultrastructural analysis (transmission elec-
tron microscopy), small vessel fragments were fixed
for 2 h in 3% glutaraldehyde, stored in Millonig buffer
(pH 7.3) and postfixed in 2% osmium tetroxide. Once
dehydrated in a graded series of acetone, the speci-
mens were embedded in Araldite to obtain thin cuts.
These sections were counterstained with lead citrate
and examined using a Zeiss 109 transmission electron
microscope.
For scanning electron microscopy, the arterial speci-
mens were opened longitudinally and immersed in
3% glutaraldehyde. Next, they were transferred to
Millonig buffer (pH 7.3) for 1 h and dehydrated in
a graded acetone series reaching critical point in
a Polaron E 3000 instrument with CO2. Once metal-
lised with gold-palladium, the specimens were exam-
ined using a Zeiss 950 DSM scanning electron
microscope.
Immunohistochemical analyses
Specimens for immunohistochemical analysis were
fixed by immersion in 10% formaldehyde and
embedded in paraffin to obtain 5 mm-thick cuts. Sec-
tions were then deparaffinated, hydrated and equili-
brated in PBS buffer (pH 7.4).
The following monoclonal antibodies against metal-
loproteinases were used as primary antibodies:
MMP-2 (gelatinase A; Binding Site Ltd., Birmingham,
U.K.) and MMP-9 (gelatinase B; Biogenesis, Sandown,
U.S.A.). The antigen-antibody reaction was visualised
using the peroxidase-antiperoxidase (PAP) method
and a rabbit-mouse staining kit (Sigma Chemical,
St Louis, MO, U.S.A). 3-Amino-9-ethyl carbazole in
N,N-dimethylformamide is the chromogenic substrate
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stained with haematoxylin.
To analyse the elastic component of the arteries
and changes incurred after cryopreservation, the
monoclonal antibody raised against human elastin
(BA-4) (Sigma, St Louis MO, U.S.A.) was used as the
primary antibody and the antigen-antibody reaction
visualised by alkaline phosphatase procedures. Fast
red was used as the chromogenic substrate. Cell nuclei
were counterstained with haematoxylin to identify
cell fractions.
To confirm the presence of mature endothelial cells
at the luminal surface after preservation, the paraffin-
embedded specimens were immunochemically
labelled with the rabbit anti-human Von Willebrand
factor (vWF) (Sigma Product No. F-3520, St Louis,
MO, U.S.A.) prepared at a dilution of 1 : 1000 and
with the mouse anti-human PECAM-1 (CD31)
(Sigma Product No. P8590, St Louis, MO, U.S.A.) at a
1 : 100 dilution. The antigen-antibody reaction was
visualised using biotinilated goat anti-rabbit/
anti-mouse IgG and ExtraAvidinTM-Alkaline
Phosphatase (Sigma, St Louis, MO, U.S.A.). The chro-
mogenic substrate used contains a-napthol phosphate
and fast red. Processed specimens were counter-
stained using acid haematoxylin and examined
under a Zeiss Axiophot light microscope (Zeiss, Jena,
Germany).
Antigen quantification
For each antibody (MMPs and elastin) and probe
used, evaluation was made of 10 transverse sections
per arterial specimen. Each section was divided into 4
sectors and one microscope field (40) was randomly
selected from each sector to estimate labelling inten-
sity, in terms of its abundance and extension, using a
MICRON computerised image analyser. An ordinate
scale from 0 to 4 was used to grade labelling as: 0,
absence (<10%); 1, minimum (10±25%); 2, moderate
(25±50%); 3, high (50±75%); and 4, maximum
(> 75%). Both control and preserved specimens were
quantified.
A descriptive statistical method was applied to the
data obtained using the computerised image analyser.
Mean values for each group were compared using the
Mann±Whitney U-test. The level of significance was
set at p5 0.05.
In situ detection of fragmented DNA
Specimens were fixed by immersion in 10% formalde-
hyde and embedded in paraffin to obtain 5 mm-thickcuts. The sections were deparaffinated, hydrated and
equilibrated in TBS buffer (pH 7.6). They were then
subjected to microwave irradiation (SANYO EM-
704T) for 5 min (350W) in 0.01M citrate buffer (pH 6).
This was followed by inactivation of endogenous per-
oxidase activity using 3% H2O2 in methanol and by
blockage of unspecific sites.
Cell death was determined by a modification of the
TUNEL method.6 This technique is based on the in situ
detection of fragmented nucleosomal DNA. In this
assay, terminal deoxynucleotidyl transferase (TdT)
binds to exposed 30-OH ends of DNA fragments
and catalyses the addition of biotin-labelled and
unlabelled deoxynucleotides. The detection of DNA
fragmentation was performed using a TdT Fragment
End Labelling kit (TdT FragELTM, Calbiochem, CN
Biosciences INC., U.S.A.). Biotinated nucleotides
were detected using a streptavidin-horseradish perox-
idase conjugate. The images were developed with a
chromogenic substrate containing DAB. Specimens
were counterstained for 5 min with methyl green.
Labelled cells were counted in 10 transverse sections
per arterial specimen per group under a Zeiss Axio-
phot light microscope (Zeiss, Jena, Germany). Each
tissue section was divided into four sectors and
labelled and unlabelled cells were counted in two
random optical fields per sector, to determine the
proportion of damaged cells in each layer of the arter-
ial wall. Counting was performed independently by
two observers. The Mann±Whitney U-test was used to
compare the proportion of TUNEL-positive cells in
each study group. Results were expressed as mean
percent of damaged cells. Differences were considered
statistically significant when p was less than 0.05.
Results
No spontaneous fractures were observed on
thawing in any of the arterial specimens subjected to
cryopreservation.
Morphological analysis
Following cryopreservation, cellular changes were
observed with respect to the fresh iliac artery. The
endothelial monolayer showed denuded patches and
subendothelial oedema, which induces cell detach-
ment processes marked by evident changes in cell
shape. The tunica media, which was mainly com-
prised of cells of normal morphology, showed punc-
tate nuclear changes in smooth muscle cells such asEur J Vasc Endovasc Surg Vol 24, July 2002
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swelling and reticular dilation.
After the period of cold-ischaemia, despite the good
general appearance of the vessels (Fig. 1a), most dam-
age affected the layers closest to the surface. The pleo-
morphic appearance of the specimens examined was
highlighted by areas of intense endothelial layer loss
interspersed with zones that were well preserved.
Endothelial cells showed signs of changes in permea-
bility including dilation of reticular bodies or clear
signs of apoptotic degeneration. The internal elastic
lamina was well-preserved (Fig. 1a). The tunica media
was of a normal, well-structured appearance, although
changes were observed in the smooth muscle cells,
those that were most damaged appearing closest to
the layer surface (Fig. 1b). The adventitia was seen to
be `` unfringed'' due to destructurisation of its fibrillar
component.
In specimens cryopreserved after cold-ischaemia,
the endothelium was also most affected and showed
denuded areas of greater extension than before cryo-
preservation, exposing fibroelastic laminae and a
dense subendothelial matrix (Fig. 2a). It should be
noted that no signs of retention of the cryopreserva-
tion solution, or zones of oedema in perielastic areas
were observed. This suggests that cryopreservation
had not induced abrupt changes in arterial patency.
Ultrastructural examination revealed how changes
were also produced in the smooth muscle cells of the
media both at the nuclear and cytoplasmic level,Fig. 1. (a) Transverse section of an artery preserved at 4 C (E: endo
generally well preserved, 500. (b) Ultrastructural appearance of a v
donor showing endothelial cell loss and medial alterations, 4400.
Eur J Vasc Endovasc Surg Vol 24, July 2002including the formation of perinuclear microvesicles
and extensive mitochondrial dilation (Fig. 2b).
Immunohistochemistry
In fresh arteries, MMP-2 staining was observed in
medial and adventitial zones, although expression
was discrete (Table 1). The cryopreservation process
did not modify this pattern, while after cold-
ischaemia, MMP-2 expression increased in intensity
and extension in all three arterial layers. Cryopreser-
vation of the ischaemic vessels resulted in the reduced
expression of this enzyme in the intima and adventi-
tia. No expression changes were detected in the media
layer. The Mann±Whitney U-test indicated no signifi-
cant differences in expression among groups
(p4 0.05).
No MMP-9 expression was recorded in any of the
vessel layers of the specimens. Minimum labelling
only was detected in the segments subjected to cold
ischaemia plus cryopreservation (Table 1).
In the fresh arteries, elastin was organised as
continuous layers, with most intense expression
observed in the internal elastic lamina that separates
the tunica intima from the media, and in the
adventitia. A delicate red elastica could be observed
throughout the muscular layer. After the period of
cold-ischaemia, the expression of this protein wasthelium, M: media, IEL: internal elastic lamina). Note the artery is
essel specimen undergoing cold-ischaemia procured from an organ
Fig. 2. (a) Denuded areas (!) of the luminal surface of an ischaemic cryopreserved arterial specimen, 500. (b) Image of the same artery
showing endothelial cells (EC) in the process of denudation and cytoplasmic and nuclear changes in cells of the medial layer (M), 3000.
Table 1. Mean values of MMP (MMP-2 and 9) and elastin expres-
sion on the arterial wall.
Fresh Fresh. Cryo Isch. Isch. Cryo
Endothelium
MMP 2 0 1 2 1
MMP 9 0 0 0 0
Elastin 2 2 2 2
Media
MMP 2 1 1 2 2
MMP 9 0 0 0 1
Elastin 3 2 3 3
Adventitia
MMP 2 1 1 2 1
MMP 9 0 0 0 1
Elastin 3 2 2 2
The scale used for quantification was as follows: 0, absence (<10%);
1, minimum (10±25%); 2, moderate (25±50%); 3, high (50±75%); and
4, maximum (> 75%).
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ganisation of laminae was noted. Elastic fragmenta-
tion was most marked after the ischaemic specimens
were cryopreserved (Fig. 3b).
To confirm the presence of endothelial cells, the
specimens were immunochemically labelled with the
rabbit anti-human Von Willebrand factor (vWF). This
technique in conjunction with the use of the mouse
anti-human PECAM-1 antibody (CD31) allowed us to
confirm the existence of mature endothelial cells on
the luminal surface of most vessel specimens. In the
fresh control group, the entire arterial segment wasendothelialised, with the tunica intima showing
immunostaining for vWf and CD31. This was also
observed in the vasa vasorum of the adventitial
layer. Ischaemia and cryopreservation led to endothe-
lial denudation in some areas of the luminal surface,
which was shown as a lack of labelling.
In situ detection of fragmented DNA
The number of TUNEL-positive cells in fresh arterial
specimens was minimal. The response to cryopreser-
vation was a non-significant increase in TUNEL-
positive cells (p 0.05). In contrast, cold ischaemia
resulted in an increased number of TUNEL-positive
cells, mainly in the endothelium, which was signifi-
cantly different to the numbers recorded in the endo-
thelium of fresh or cryopreserved specimens
(p5 0.05). After ischaemia followed by cryopreserva-
tion, a large proportion of endothelial cells showed
positivity for the TUNEL technique. However, no
significant difference was observed between the
ischaemic and the ischaemic/cryopreserved speci-
mens in any of the vessel layers (p 0.05), while sig-
nificant differences were observed between the
endothelial layer of this group with respect to that of
the fresh and fresh cryopreserved specimens
(p5 0.05). No inter- or intra-group differences in
TUNEL positive cells were shown for the muscular
and adventitial layers.Eur J Vasc Endovasc Surg Vol 24, July 2002
Fig. 3. (a) Elastin expression after cold ischaemia. Greatest intensity of labelling was noted in the internal elastic lamina and adventitia ().
Labelling defined continuous layers in the media (E: endothelium, M: media, A: adventitia), 400. (b) Intense elastic fragmentation (!)
following cryopreservation (M: media), 400.
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The present findings suggest that during the period of
cold-ischaemia, the arterial wall suffers considerable
damage but that this insult is not significantly further
affected by subsequent cryopreservation. The vessel
is thus able to preserve its structural and functional
characteristics, possibly allowing its subsequent
use.3,4,7±16
Blood vessels express different degrees of tolerance
to cryopreservation procedures due to their different
cell types.17,18 Regional variations in the same artery
also provoke different responses to freezing injury.19
Vessels for cryopreservation are presently obtained
from organ donors.
Cold-ischaemia is the most widely used method of
storage. These organs are perfused with preservation
solutions and then stored at 0±4 C, for short periods.
The problem arises when storage is prolonged.20,21Eur J Vasc Endovasc Surg Vol 24, July 2002In the present investigation following prolonged
cold storage some areas of the endothelial surface
were lost, while others showed no denudation what-
soever after 4 days. Similar findings were reported as
early as 24±48 h.22 or longer (7 days) in iliac arteries
and veins.23 In vitro experiments performed at 4 C on
pig endothelial cells24 suggest that long-term preser-
vation (8 h) causes a loss in endothelial functionality
that may account for post-transplant complications.
It has also been proposed25 that ultrastructural cell
damage produced in response to cold storage may
be fully reversed by a short warming period at 37 C.
However, this has only been confirmed in endothelial
cell cultures and not in whole tissue or using other
long-term preservation methods.26
Both in terms of DNA fragmentation and mmp
activity matrix, it would seem that prolonged cold-
ischaemia induces substantial damage to the arterial
wall.
Fig. 4. Proportions of TUNEL-positive cells in the different layers of
the artery wall (p5 0.05).
Cryopreserved Ischaemic Vessel Substitutes 29The changes induced in the normal artery by cryo-
preservation were not un expected,26,27 particularly
after slow thawing.1,2 The freezing and thawing
temperature rate is an important factor that needs to
be controlled in cryopreservation protocols.
In conclusion, it would appear that despite the
damage induced by ischaemia, the characteristics of
the artery's structural framework are such that it
could be directly used as a vascular prosthesis with
certain limitations. Alternatively, the cryopreserved
ischaemic artery may prove to be the ideal scaffold
for colonisation by autologous cells via tissue engi-
neering procedures to give rise to a semi-autologous
vascular prosthesis.
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